Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Modification of Carbon Nitride/Reduced Graphene Oxide van der Waals Heterostructure with Copper Nanoparticles to Improve CO2 Sensitivity.

Ellis JE, Sorescu DC, Hwang SI, Burkert S, White DL, Kim H, Star A.

ACS Appl Mater Interfaces. 2019 Oct 11. doi: 10.1021/acsami.9b13440. [Epub ahead of print]

PMID:
31601095
2.

The Resident VIEW in Nursing Homes.

White DL, Tunalilar O, Hasworth S, Winfree J.

Gerontol Geriatr Med. 2019 Sep 26;5:2333721419877975. doi: 10.1177/2333721419877975. eCollection 2019 Jan-Dec.

3.

Tetrahydrocannabinol Detection Using Semiconductor-Enriched Single-Walled Carbon Nanotube Chemiresistors.

Hwang SI, Franconi NG, Rothfuss MA, Bocan KN, Bian L, White DL, Burkert SC, Euler RW, Sopher BJ, Vinay ML, Sejdic E, Star A.

ACS Sens. 2019 Aug 23;4(8):2084-2093. doi: 10.1021/acssensors.9b00762. Epub 2019 Aug 1.

PMID:
31321969
4.

Dietary quality and the colonic mucosa-associated gut microbiome in humans.

Liu Y, Ajami NJ, El-Serag HB, Hair C, Graham DY, White DL, Chen L, Wang Z, Plew S, Kramer J, Cole R, Hernaez R, Hou J, Husain N, Jarbrink-Sehgal ME, Kanwal F, Ketwaroo G, Natarajan Y, Shah R, Velez M, Mallepally N, Petrosino JF, Jiao L.

Am J Clin Nutr. 2019 Sep 1;110(3):701-712. doi: 10.1093/ajcn/nqz139.

PMID:
31291462
5.

Probing Ca2+-induced conformational change of calmodulin with gold nanoparticle-decorated single-walled carbon nanotube field-effect transistors.

Shao W, Burkert SC, White DL, Scott VL, Ding J, Li Z, Ouyang J, Lapointe F, Malenfant PRL, Islam K, Star A.

Nanoscale. 2019 Jul 28;11(28):13397-13406. doi: 10.1039/c9nr03132d. Epub 2019 Jul 5.

PMID:
31276143
6.

Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014.

White DL, Oluyomi A, Royse K, Dong Y, Nguyen H, Chang E, Richardson P, Jiao L, Garcia JM, Kramer JR, Thrift AP, Chiao E.

J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):387-394. doi: 10.1097/QAI.0000000000002050.

PMID:
31242141
7.

Validation of HIV-infected cohort identification using automated clinical data in the Department of Veterans Affairs.

Kramer JR, Hartman C, White DL, Royse K, Richardson P, Thrift AP, Raychaudhury S, Desiderio R, Sanchez D, Chiao EY.

HIV Med. 2019 Sep;20(8):567-570. doi: 10.1111/hiv.12757. Epub 2019 May 26.

PMID:
31131549
8.

Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib.

Kok CH, Yeung DT, Lu L, Watkins DB, Leclercq TM, Dang P, Saunders VA, Reynolds J, White DL, Hughes TP.

Blood Adv. 2019 May 28;3(10):1610-1621. doi: 10.1182/bloodadvances.2019000195.

9.

NLRP3 inflammasome activation in platelets in response to sepsis.

Cornelius DC, Baik CH, Travis OK, White DL, Young CM, Austin Pierce W, Shields CA, Poudel B, Williams JM.

Physiol Rep. 2019 May;7(9):e14073. doi: 10.14814/phy2.14073.

10.

Holey Graphene Metal Nanoparticle Composites via Crystalline Polymer Templated Etching.

White DL, Burkert SC, Hwang SI, Star A.

Nano Lett. 2019 May 8;19(5):2824-2831. doi: 10.1021/acs.nanolett.8b04755. Epub 2019 Apr 15.

PMID:
30958007
11.

The Impact of Communication Impairments on the Social Relationships of Older Adults: Pathways to Psychological Well-Being.

Palmer AD, Carder PC, White DL, Saunders G, Woo H, Graville DJ, Newsom JT.

J Speech Lang Hear Res. 2019 Jan 30;62(1):1-21. doi: 10.1044/2018_JSLHR-S-17-0495.

PMID:
30950760
12.

Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study.

Thrift AP, Kramer JR, Hartman CM, Royse K, Richardson P, Dong Y, Raychaudhury S, Desiderio R, Sanchez D, Anandasabapathy S, White DL, Chiao EY.

J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):e65-e72. doi: 10.1097/QAI.0000000000002038.

PMID:
30939533
13.

Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia.

Ross DM, Pagani IS, Irani YD, Clarson J, Leclercq T, Dang P, McLean J, Saunders VA, Carne L, Reynolds J, Ritchie DS, White DL, Branford S, Hughes TP, Yong ASM.

Br J Haematol. 2019 Aug;186(3):e56-e60. doi: 10.1111/bjh.15894. Epub 2019 Mar 27. No abstract available.

PMID:
30916385
14.

Dietary Nutrients Involved in One-Carbon Metabolism and Colonic Mucosa-Associated Gut Microbiome in Individuals with an Endoscopically Normal Colon.

Gurwara S, Ajami NJ, Jang A, Hessel FC, Chen L, Plew S, Wang Z, Graham DY, Hair C, White DL, Kramer J, Kourkoumpetis T, Hoffman K, Cole R, Hou J, Husain N, Jarbrink-Sehgal M, Hernaez R, Kanwal F, Ketwaroo G, Shah R, Velez M, Natarajan Y, El-Serag HB, Petrosino JF, Jiao L.

Nutrients. 2019 Mar 13;11(3). pii: E613. doi: 10.3390/nu11030613.

15.

Ultrasound guidance for sural nerve conduction studies.

Cartwright MS, White DL, Hollinger JS, Krzesniak-Swinarska M, Caress JB, Walker FO.

Muscle Nerve. 2019 Jun;59(6):705-707. doi: 10.1002/mus.26465. Epub 2019 Mar 26.

PMID:
30868637
16.

Growth of ZIF-8 on molecularly ordered 2-methylimidazole/single-walled carbon nanotubes to form highly porous, electrically conductive composites.

Ellis JE, Zeng Z, Hwang SI, Li S, Luo TY, Burkert SC, White DL, Rosi NL, Gassensmith JJ, Star A.

Chem Sci. 2018 Oct 25;10(3):737-742. doi: 10.1039/c8sc03987a. eCollection 2019 Jan 21.

17.

Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis.

Tayob N, Christie I, Richardson P, Feng Z, White DL, Davila J, Corley DA, Kanwal F, El-Serag HB.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1886-1893.e5. doi: 10.1016/j.cgh.2018.12.005. Epub 2018 Dec 14.

PMID:
30557738
18.

Machine-Learning Identification of the Sensing Descriptors Relevant in Molecular Interactions with Metal Nanoparticle-Decorated Nanotube Field-Effect Transistors.

Bian L, Sorescu DC, Chen L, White DL, Burkert SC, Khalifa Y, Zhang Z, Sejdic E, Star A.

ACS Appl Mater Interfaces. 2019 Jan 9;11(1):1219-1227. doi: 10.1021/acsami.8b15785. Epub 2018 Dec 28.

PMID:
30547572
19.

Modelling ponatinib resistance in tyrosine kinase inhibitor-naïve and dasatinib resistant BCR-ABL1+ cell lines.

Lu L, Kok CH, Saunders VA, Wang J, McLean JA, Hughes TP, White DL.

Oncotarget. 2018 Oct 5;9(78):34735-34747. doi: 10.18632/oncotarget.26187. eCollection 2018 Oct 5.

20.

Ancestry and Risk of Hepatic Fibrosis and Inflammation in Patients With HCV Infection.

Thrift AP, Liu Y, Tsavachidis S, White DL, El-Serag HB.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1912-1914. doi: 10.1016/j.cgh.2018.10.024. Epub 2018 Oct 18.

PMID:
30342914
21.

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells.

Ross DM, Pagani IS, Shanmuganathan N, Kok CH, Seymour JF, Mills AK, Filshie RJ, Arthur CK, Dang P, Saunders VA, Braley J, Yong AS, Yeung DT, White DL, Grigg AP, Schwarer AP, Branford S, Hughes TP; Australasian Leukaemia and Lymphoma Group (ALLG).

Leukemia. 2018 Dec;32(12):2572-2579. doi: 10.1038/s41375-018-0264-0. Epub 2018 Oct 12.

PMID:
30315232
22.

Targeting myeloid regulators by paclitaxel-loaded enzymatically degradable nanocups.

Burkert SC, Shurin GV, White DL, He X, Kapralov AA, Kagan VE, Shurin MR, Star A.

Nanoscale. 2018 Sep 27;10(37):17990-18000. doi: 10.1039/c8nr04437f.

23.

Anti-Hypertensive Medication Use, Soluble Receptor for Glycation End Products and Risk of Pancreatic Cancer in the Women's Health Initiative Study.

Wang Z, White DL, Hoogeveen R, Chen L, Whitsel EA, Richardson PA, Virani SS, Garcia JM, El-Serag HB, Jiao L.

J Clin Med. 2018 Aug 2;7(8). pii: E197. doi: 10.3390/jcm7080197.

24.

Nivolumab Treatment for Cancers in the HIV-infected Population.

Chang E, Sabichi AL, Kramer JR, Hartman C, Royse KE, White DL, Patel NR, Richardson P, Yellapragada SV, Garcia JM, Chiao EY.

J Immunother. 2018 Oct;41(8):379-383. doi: 10.1097/CJI.0000000000000240.

25.

Impact of Protease Inhibitors on HIV-Associated Kaposi Sarcoma Incidence: A Systematic Review.

Chang E, Mapakshi SR, Mbang P, El-Mallawany NK, Kramer JR, White DL, Chiao EY.

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):141-148. doi: 10.1097/QAI.0000000000001798.

PMID:
29985803
26.

BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia.

Pagani IS, Dang P, Kommers IO, Goyne JM, Nicola M, Saunders VA, Braley J, White DL, Yeung DT, Branford S, Hughes TP, Ross DM.

Haematologica. 2018 Dec;103(12):2026-2032. doi: 10.3324/haematol.2018.189787. Epub 2018 Jul 5.

27.

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease.

Branford S, Wang P, Yeung DT, Thomson D, Purins A, Wadham C, Shahrin NH, Marum JE, Nataren N, Parker WT, Geoghegan J, Feng J, Shanmuganathan N, Mueller MC, Dietz C, Stangl D, Donaldson Z, Altamura H, Georgievski J, Braley J, Brown A, Hahn C, Walker I, Kim SH, Choi SY, Park SH, Kim DW, White DL, Yong ASM, Ross DM, Scott HS, Schreiber AW, Hughes TP.

Blood. 2018 Aug 30;132(9):948-961. doi: 10.1182/blood-2018-02-832253. Epub 2018 Jul 2.

PMID:
29967129
28.

Precision medicine approaches may be the future for CRLF2 rearranged Down Syndrome Acute Lymphoblastic Leukaemia patients.

Page EC, Heatley SL, Yeung DT, Thomas PQ, White DL.

Cancer Lett. 2018 Sep 28;432:69-74. doi: 10.1016/j.canlet.2018.05.045. Epub 2018 Jun 4. Review.

PMID:
29879498
29.

Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten.

Nair SS, Luu PL, Qu W, Maddugoda M, Huschtscha L, Reddel R, Chenevix-Trench G, Toso M, Kench JG, Horvath LG, Hayes VM, Stricker PD, Hughes TP, White DL, Rasko JEJ, Wong JJ, Clark SJ.

Epigenetics Chromatin. 2018 May 28;11(1):24. doi: 10.1186/s13072-018-0194-0.

30.

Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy.

Shields CA, McCalmon M, Ibrahim T, White DL, Williams JM, LaMarca B, Cornelius DC.

Am J Physiol Regul Integr Comp Physiol. 2018 Aug 1;315(2):R336-R343. doi: 10.1152/ajpregu.00061.2018. Epub 2018 May 2.

31.

Patients with low OCT-1 activity and high ABCB1 fold rise have poor long-term outcomes in response to tyrosine kinase inhibitor therapy.

Eadie LN, Hughes TP, White DL.

Leukemia. 2018 Oct;32(10):2288-2291. doi: 10.1038/s41375-018-0101-5. Epub 2018 Mar 23. No abstract available.

PMID:
29654270
32.

A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.

White DL, Hoogeveen RC, Chen L, Richardson P, Ravishankar M, Shah P, Tinker L, Rohan T, Whitsel EA, El-Serag HB, Jiao L.

Cancer Med. 2018 May;7(5):2180-2191. doi: 10.1002/cam4.1426. Epub 2018 Mar 23.

33.

The new allosteric inhibitor asciminib is susceptible to resistance mediated by ABCB1 and ABCG2 overexpression in vitro.

Eadie LN, Saunders VA, Branford S, White DL, Hughes TP.

Oncotarget. 2018 Feb 3;9(17):13423-13437. doi: 10.18632/oncotarget.24393. eCollection 2018 Mar 2.

34.

Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.

McClure BJ, Heatley SL, Kok CH, Sadras T, An J, Hughes TP, Lock RB, Yeung D, Sutton R, White DL.

Br J Cancer. 2018 Apr;118(7):1000-1004. doi: 10.1038/s41416-018-0022-0. Epub 2018 Mar 13.

35.

ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells.

Eadie LN, Dang P, Goyne JM, Hughes TP, White DL.

PLoS One. 2018 Jan 31;13(1):e0192180. doi: 10.1371/journal.pone.0192180. eCollection 2018. Erratum in: PLoS One. 2018 Aug 31;13(8):e0203583.

36.

Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.

Tayob N, Richardson P, White DL, Yu X, Davila JA, Kanwal F, Feng Z, El-Serag HB.

BMC Med Res Methodol. 2018 Jan 4;18(1):1. doi: 10.1186/s12874-017-0458-6.

37.

A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH.

Sadras T, Heatley SL, Kok CH, McClure BJ, Yeung D, Hughes TP, Sutton R, Ziegler DS, White DL.

Cancer Genet. 2017 Oct;216-217:86-90. doi: 10.1016/j.cancergen.2017.07.008. Epub 2017 Jul 31.

PMID:
29025600
38.

High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.

Heatley SL, Sadras T, Kok CH, Nievergall E, Quek K, Dang P, McClure B, Venn N, Moore S, Suttle J, Law T, Ng A, Muskovic W, Norris MD, Revesz T, Osborn M, Moore AS, Suppiah R, Fraser C, Alvaro F, Hughes TP, Mullighan CG, Marshall GM, Pozza LD, Yeung DT, Sutton R, White DL.

Haematologica. 2017 Dec;102(12):e490-e493. doi: 10.3324/haematol.2016.162925. Epub 2017 Sep 21. No abstract available.

39.

Sleep Duration and Risk of Liver Cancer in Postmenopausal Women: The Women's Health Initiative Study.

Royse KE, El-Serag HB, Chen L, White DL, Hale L, Sangi-Haghpeykar H, Jiao L.

J Womens Health (Larchmt). 2017 Dec;26(12):1270-1277. doi: 10.1089/jwh.2017.6412. Epub 2017 Sep 21.

40.

Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.

Jiao L, Chen L, White DL, Tinker L, Chlebowski RT, Van Horn LV, Richardson P, Lane D, Sangi-Haghpeykar H, El-Serag HB.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx117.

41.

Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions.

Sadras T, Heatley SL, Kok CH, Dang P, Galbraith KM, McClure BJ, Muskovic W, Venn NC, Moore S, Osborn M, Revesz T, Moore AS, Hughes TP, Yeung D, Sutton R, White DL.

Cancer Lett. 2017 Nov 1;408:92-101. doi: 10.1016/j.canlet.2017.08.034. Epub 2017 Sep 1.

PMID:
28866095
42.

Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.

Kramer JR, El-Serag HB, Taylor TJ, White DL, Asch SM, Frayne SM, Cao Y, Smith DL, Kanwal F.

J Viral Hepat. 2017 Nov;24(11):955-965. doi: 10.1111/jvh.12728. Epub 2017 Aug 16.

43.

Coughing, sneezing, and aching online: Twitter and the volume of influenza-like illness in a pediatric hospital.

Hartley DM, Giannini CM, Wilson S, Frieder O, Margolis PA, Kotagal UR, White DL, Connelly BL, Wheeler DS, Tadesse DG, Macaluso M.

PLoS One. 2017 Jul 28;12(7):e0182008. doi: 10.1371/journal.pone.0182008. eCollection 2017.

44.

Uncondensed Graphitic Carbon Nitride on Reduced Graphene Oxide for Oxygen Sensing via a Photoredox Mechanism.

Ellis JE, Sorescu DC, Burkert SC, White DL, Star A.

ACS Appl Mater Interfaces. 2017 Aug 16;9(32):27142-27151. doi: 10.1021/acsami.7b06017. Epub 2017 Aug 7.

45.

A Method for Next-Generation Sequencing of Paired Diagnostic and Remission Samples to Detect Mitochondrial DNA Mutations Associated with Leukemia.

Pagani IS, Kok CH, Saunders VA, Van der Hoek MB, Heatley SL, Schwarer AP, Hahn CN, Hughes TP, White DL, Ross DM.

J Mol Diagn. 2017 Sep;19(5):711-721. doi: 10.1016/j.jmoldx.2017.05.009. Epub 2017 Jul 18.

PMID:
28732215
46.

Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinoma.

Royse KE, Chen L, Berger DH, Ittmann MM, El-Serag HB, Balentine CJ, Graham DY, Richardson PA, Rumbaut RE, Shen X, White DL, Jiao L.

Int J Mol Epidemiol Genet. 2017 Apr 15;8(2):8-18. eCollection 2017.

47.

Applying the Chronic Care Model to Improve Care and Outcomes at a Pediatric Medical Center.

Lail J, Schoettker PJ, White DL, Mehta B, Kotagal UR.

Jt Comm J Qual Patient Saf. 2017 Mar;43(3):101-112. doi: 10.1016/j.jcjq.2016.12.002. Epub 2017 Jan 13.

PMID:
28334588
48.

Fabrication of Holey Graphene: Catalytic Oxidation by Metalloporphyrin-Based Covalent Organic Framework Immobilized on Highly Ordered Pyrolytic Graphite.

Seo W, White DL, Star A.

Chemistry. 2017 Apr 27;23(24):5652-5657. doi: 10.1002/chem.201605488. Epub 2017 Mar 27.

49.

Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells.

Wang J, Lu L, Kok CH, Saunders VA, Goyne JM, Dang P, Leclercq TM, Hughes TP, White DL.

Haematologica. 2017 May;102(5):843-853. doi: 10.3324/haematol.2016.153270. Epub 2017 Feb 2.

50.

CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors.

Hughes A, Clarson J, Tang C, Vidovic L, White DL, Hughes TP, Yong AS.

Blood. 2017 Mar 2;129(9):1166-1176. doi: 10.1182/blood-2016-10-745992. Epub 2017 Jan 3.

PMID:
28049640

Supplemental Content

Loading ...
Support Center